Pioneering Alzheimer’s Study Seeks Hispanic Volunteers in Florida

The Bio-Hermes study will not close until 20% of its volunteers are Hispanic/Latinx, and/or African American/Black. This article is also available in Spanish. A clinical trial could lead to the creation of biomarker-based rapid Alzheimer’s tests. The research called Biohermes will include older Hispanics in the study, announced the Global Alzheimer’s Platform Foundation (GAP). The study will be carried out in […]

Read More…

Global testing: Inland Northwest Research Joins International Parkinson’s Clinical Trial to Determine if Investigational Drug Slows Progression

GAP-Net site, Inland Northwest Research, and GAP President, John Dwyer, talk about the Parkinson’s disease study, PADOVA, and what it hopes to achieve. A Parkinson’s disease clinical trial is launching at 120 global sites – including Spokane – to do a broader test of an investigational drug that in an earlier phase indicated it slowed […]

Read More…

Syracuse Research Group Looking for Volunteers to Identify Risks for Alzheimer’s

GAP-Net site, Clarity Clinical Research, was featured on CNYCentral about their participation in the Bio-Hermes study. Clarity Clinical Research, a Syracuse research group, is looking for volunteers in an Alzheimer’s risk study. The study includes three visits with no-cost amyloid PET scans that are designed to predict or possibly diagnose Alzheimer’s disease. Brain amyloid plaques […]

Read More…

Victor Company Plays Role in World-Wide Study, Seeking to Improve Alzheimer’s Detection

GAP President John Dwyer was on RochesterFirst.com to talk about the ground breaking Bio-Hermes study and what it means for the future of Alzheimer’s detection. Click here to watch the full interview.  In the next few years – we could expect Alzheimer’s detection to be as easy and accessible as ordering up a blood test, […]

Read More…

Bio-Hermes: Making Alzheimer’s Diagnosis Fast, Cheap, Accessible

GAP President John Dwyer spoke to Alzforum about the Bio-Hermes study. With disease-modifying treatments for Alzheimer’s disease potentially on the cusp of approval, there will be pressing demand for quick, simple ways to screen patients and determine if they have amyloid plaque in their brains. The current gold-standard diagnostics used in research—amyloid PET scans and […]

Read More…

Syracuse Researchers Seek Volunteers for Free Brain Scan that Predicts Alzheimer’s

GAP-Net Site Clarity Clinical Research talks about their participation in GAP’s Bio-Hermes Study. Syracuse, N.Y. — A Syracuse research clinic is seeking volunteers for a brain scan that may help predict or diagnose Alzheimer’s disease before symptoms appear. Clarity Clinical Research is one of 10 clinics nationwide offering no cost Amyloid PET scans as part […]

Read More…

They Have Alzheimer’s. This Clinical Trial May Be a Last Hope.

GAP President John Dwyer was quoted in a New York Times article along side three Alzheimer’s volunteer participants in the donanemab clinical trial by Lilly, a GAP partner. Despite the urgent need for treatments to slow or stop Alzheimer’s disease, finding patients for clinical trials has been difficult and frustrating. Patients are often older. Their […]

Read More…

USF Awarded Five-Year, $44.4 Million NIH Grant to Test Whether Computerized Brain Training Reduces Dementia Risk

GAP-Net site USF Health has received a grant from the NIH to study a computerized brain training exercise, and if it can reduce the disk of Alzheimer’s disease and other dementias. The National Institutes of Health (NIH) has awarded the University of South Florida (USF) total expected funds of $44.4 million over the next five […]

Read More…

KU Alzheimer’s Disease Center Receives Over $1 Million for Research

GAP-Net Site KU ADC has received over $1.3 million to research how exercise supports the brain as humans age. TOPEKA, Kan. (WIBW) – The University of Kansas Alzheimer’s Disease Center has received over $1 million to research how exercise could prevent Alzheimer’s. Senator Roger Marshall (R-Kan.) says the University of Kansas Alzheimer’s Disease Center has […]

Read More…

KU Alzheimer’s Disease Center Using $4.3 Million NIH Grant to Power its Research and Dementia Care Efforts

GAP-Net site Kansas University ADC was granted $4.3 million from the NIH to elevate dementia care in Kansas communities. Dementia researchers are convinced the path to beating back the life-robbing disease goes directly through clinical trials fueled by research volunteers willing to join the battle. That’s why the experts at the University of Kansas Alzheimer’s Disease […]

Read More…